We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$20.8B
AUM Growth
+$3.81B
Cap. Flow
+$2.41B
Cap. Flow %
11.56%
Top 10 Hldgs %
30.36%
Holding
2,920
New
199
Increased
391
Reduced
1,521
Closed
76

Sector Composition

Rank Sector Weight
1 Technology 30.99%
2 Financials 13.3%
3 Consumer Discretionary 10.8%
4 Healthcare 9.36%
5 Industrials 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIP icon
2126
FTAI Infrastructure
FIP
$551M
$274K ﹤0.01%
62,861
-1,366
-2% -$7.4K
FPI
2127
Farmland Partners
FPI
$425M
$273K ﹤0.01%
25,062
-4,482
-15% -$49.1K
MOFG
2128
DELISTED
MidWestOne Financial Group
MOFG
$272K ﹤0.01%
9,620
-3,158
-25% -$92.1K
AQST icon
2129
Aquestive Therapeutics
AQST
$533M
$272K ﹤0.01%
48,650
-1,374
-3% -$5.94K
AEBI
2130
Aebi Schmidt Holding AG
AEBI
$1.06B
$271K ﹤0.01%
+21,717
New +$273K
RDW icon
2131
Redwire
RDW
$3.3B
$271K ﹤0.01%
30,103
+9,464
+46% +$111K
NLOP
2132
Net Lease Office Properties
NLOP
$173M
$270K ﹤0.01%
9,103
-6
-0.1% -$188
AEVA
2133
Aeva Technologies
AEVA
$1.56B
$270K ﹤0.01%
18,592
FMNB icon
2134
Farmers National Banc Corp
FMNB
$970M
$267K ﹤0.01%
18,548
-3,316
-15% -$47.5K
CODI icon
2135
Compass Diversified
CODI
$924M
$267K ﹤0.01%
40,372
TW icon
2136
Tradeweb Markets
TW
$22.3B
$267K ﹤0.01%
2,407
+20
+0.8% +$2.57K
PVLA
2137
Palvella Therapeutics
PVLA
$2.26B
$267K ﹤0.01%
4,260
GOSS icon
2138
Gossamer Bio
GOSS
$83.3M
$267K ﹤0.01%
101,513
-14,300
-12% -$31.5K
CARE icon
2139
Carter Bankshares
CARE
$757M
$266K ﹤0.01%
13,692
TIPT icon
2140
Tiptree Inc
TIPT
$677M
$265K ﹤0.01%
13,814
BHB icon
2141
Bar Harbor Bankshares
BHB
$681M
$265K ﹤0.01%
+8,686
New +$272K
IMXI icon
2142
International Money Express
IMXI
$353M
$265K ﹤0.01%
18,937
VSTS icon
2143
Vestis
VSTS
$1.79B
$265K ﹤0.01%
58,393
-11,990
-17% -$61.5K
DAWN
2144
DELISTED
Day One Biopharmaceuticals
DAWN
$264K ﹤0.01%
37,478
-6,964
-16% -$47.9K
KALV
2145
DELISTED
KalVista Pharmaceuticals
KALV
$264K ﹤0.01%
21,688
MLR icon
2146
Miller Industries
MLR
$640M
$264K ﹤0.01%
6,526
BAND
2147
Bandwidth Inc
BAND
$1.74B
$263K ﹤0.01%
15,796
FFIC
2148
DELISTED
Flushing Financial
FFIC
$263K ﹤0.01%
19,037
-3,597
-16% -$46.8K
BFS
2149
Saul Centers
BFS
$865M
$262K ﹤0.01%
8,207
+4
+0% +$132
WRLD icon
2150
World Acceptance Corp
WRLD
$875M
$261K ﹤0.01%
1,546
-520
-25% -$87.5K

Similar funds

MetLife Investment Management's Q3 2025 Portfolio in Review

As of Q3 2025, MetLife Investment Management held 2,920 positions worth $20.8B, up 22% from $17B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

MetLife Investment Management deployed $2.41B of net new capital in Q3 2025, opening 199 new positions and adding to 391 existing holdings. Its largest new stake was Apple: 4,311,733 shares worth $1.1B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $37.1M trimmed.

  • MetLife Investment Management's largest Q3 2025 buy was Apple: 4,311,733 shares worth $1.1B.
  • MetLife Investment Management added most to Applovin in Q3 2025, an estimated $29.1M increase.
  • MetLife Investment Management's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $37.1M.
  • MetLife Investment Management fully exited RTX Corp in Q3 2025, selling an estimated $49.7M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $20.8B portfolio in Q3 2025.
  • MetLife Investment Management opened 199 new positions and closed 76 in Q3 2025.
  • MetLife Investment Management's portfolio value rose 22% quarter-over-quarter to $20.8B.

Based on MetLife Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.